International Association of
Therapeutic Drug Monitoring and Clinical Toxicology
Fostering education, research and practice in TDM and CT

Young Scientist Abstracts - Archived Files

2013

Ketamine-derived designer drug methoxetamine: metabolism including isoenzyme kinetics and toxicological detectability using GC-MS and LC-(HR-)MSn.
http://www.ncbi.nlm.nih.gov/pubmed/23774830

Meyer MR1, Bach M1, Welter J1, Bovens M2, Turcant A3, Maurer HH1
1Department of Experimental and Clinical Toxicology, Saarland University, Homburg (Saar), Germany
2Forensic Science Institute, Zürich, Switzerland
3Laboratoire de Pharmacologie-Toxicologie, CHU, Angers, France

 

Anal Bioanal Chem.2013;405(19):6307-21

Lessons from routine dose adjustment of tacrolimus in renal transplant patients based on global exposure.
http://www.ncbi.nlm.nih.gov/pubmed/23666572

Saint-Marcoux F1,2, Woillard JB1,2, Jurado C1, Marquet P1,2
1Department of Pharmacology, Limoges University Hospital, Limoges, France
2INSERM, UMR-S850, University of Limoges, France

 

Ther Drug Monit.2013;35(3):322-7

Studies on the metabolism and detectability of the designer drug β-naphyrone in rat urine using GC-MS and LC-HR-MS/MS.
http://www.ncbi.nlm.nih.gov/pubmed/23303532

Meyer MR1, Prosser D1, Maurer HH1
1Department of Experimental and Clinical Toxicology, Saarland University, Homburg (Saar), Germany

 

Drug Test Anal.2013;5(4):259-65

Driving under the influence of cannabis: pitfalls, validation, and quality control of a UPLC-MS/MS method for the quantification of tetrahydrocannabinol in oral fluid collected with StatSure, Quantisal, or Certus collector.
http://www.ncbi.nlm.nih.gov/pubmed/23318281

Wille SM1, Di Fazio V1, Ramírez-Fernandez Mdel M1, Kummer N1, Samyn N1
1Laboratory of Toxicology, National Institute of Criminalistics and Criminology, Brussels, Belgium

 

Ther Drug Monit.2013;35(1):101-11